Source link : https://www.newshealth.biz/health-news/psilocybin-vs-lexapro-fdas-karxt-decision-nears-obesity-and-schizophrenia/
In a phase II trial of moderate-to-severe major depressive disorder, 6 weeks of intensive treatment with psilocybin or escitalopram (Lexapro) plus psychological support were tied to improvements in depression symptom severity at 6 months, but only psilocybin was associated with better measures of social functioning, psychological connectedness, and meaning in life. (eClinicalMedicine) High doses of […]
Author : News Health
Publish date : 2024-09-25 17:56:25
Copyright for syndicated content belongs to the linked Source.
Categories